Description

Salbutamol 4 mg by Swiss Healthcare is a pharmaceutical-grade oral β2-adrenergic agonist, historically used in medical settings to treat bronchospasm and asthma. In research environments, Salbutamol has been investigated for its thermogenic properties, fat metabolism effects, and potential muscle-preserving activity due to its stimulant-like impact on β2 receptors in skeletal muscle and adipose tissue.

As a fast-acting beta-agonist, Salbutamol promotes bronchodilation and increases metabolic rate, making it a relevant compound in studies related to respiratory function, energy expenditure, and body composition. Unlike Clenbuterol, Salbutamol has a shorter half-life and is generally considered to have a more favorable safety profile when properly controlled in experimental settings.

Each bottle contains 60 oral tablets of 4 mg Salbutamol, manufactured to exacting pharmaceutical standards for precision dosing in laboratory studies.

Product Details

• Active Ingredient: Salbutamol Sulfate

• Concentration per Tablet: 4 mg

• Form: Oral tablets

• Package Size: 60 tablets per bottle

Pharmacokinetics

Salbutamol has a rapid onset of action and a short half-life of approximately 3–6 hours, requiring multiple daily administrations in studies. It exhibits high β2-selectivity, reducing off-target cardiovascular stimulation compared to non-selective adrenergics.

Usage Recommendations

• Typical Research Dosage (historical reference): 4–8 mg, 2–3 times per day

• Current Use: Intended solely for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human medical use or consumption. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with cardiovascular or neurological conditions. Always follow local laws and professional handling protocols.